Exact Sciences
Developer and manufacturer of cologuard, a non-invasive screening test for the early detection of colorectal cancer. Learn more
Launch date
Employees
Market cap
CAD17.0b
Enterprise valuation
CAD19.5b (Public information from Sep 2024)
Share price
$69.21 EXAS
Madison Wisconsin (HQ)
No columns specified